Skip to main content

The relationship between LHRH-agonist depot formulations and frequency of follow-up with health care providers in patients with prostate cancer

Publication ,  Conference
Moul, JW; Wiederkehr, D; Connolly, M; Sendersky, V; Onel, E
Published in: Journal of Clinical Oncology
May 20, 2008

Duke Scholars

Published In

Journal of Clinical Oncology

DOI

EISSN

1527-7755

ISSN

0732-183X

Publication Date

May 20, 2008

Volume

26

Issue

15_suppl

Start / End Page

16002 / 16002

Publisher

American Society of Clinical Oncology (ASCO)

Related Subject Headings

  • Oncology & Carcinogenesis
  • 3211 Oncology and carcinogenesis
  • 1112 Oncology and Carcinogenesis
  • 1103 Clinical Sciences
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Moul, J. W., Wiederkehr, D., Connolly, M., Sendersky, V., & Onel, E. (2008). The relationship between LHRH-agonist depot formulations and frequency of follow-up with health care providers in patients with prostate cancer. In Journal of Clinical Oncology (Vol. 26, pp. 16002–16002). American Society of Clinical Oncology (ASCO). https://doi.org/10.1200/jco.2008.26.15_suppl.16002
Moul, J. W., D. Wiederkehr, M. Connolly, V. Sendersky, and E. Onel. “The relationship between LHRH-agonist depot formulations and frequency of follow-up with health care providers in patients with prostate cancer.” In Journal of Clinical Oncology, 26:16002–16002. American Society of Clinical Oncology (ASCO), 2008. https://doi.org/10.1200/jco.2008.26.15_suppl.16002.
Moul JW, Wiederkehr D, Connolly M, Sendersky V, Onel E. The relationship between LHRH-agonist depot formulations and frequency of follow-up with health care providers in patients with prostate cancer. In: Journal of Clinical Oncology. American Society of Clinical Oncology (ASCO); 2008. p. 16002–16002.
Moul, J. W., et al. “The relationship between LHRH-agonist depot formulations and frequency of follow-up with health care providers in patients with prostate cancer.” Journal of Clinical Oncology, vol. 26, no. 15_suppl, American Society of Clinical Oncology (ASCO), 2008, pp. 16002–16002. Crossref, doi:10.1200/jco.2008.26.15_suppl.16002.
Moul JW, Wiederkehr D, Connolly M, Sendersky V, Onel E. The relationship between LHRH-agonist depot formulations and frequency of follow-up with health care providers in patients with prostate cancer. Journal of Clinical Oncology. American Society of Clinical Oncology (ASCO); 2008. p. 16002–16002.

Published In

Journal of Clinical Oncology

DOI

EISSN

1527-7755

ISSN

0732-183X

Publication Date

May 20, 2008

Volume

26

Issue

15_suppl

Start / End Page

16002 / 16002

Publisher

American Society of Clinical Oncology (ASCO)

Related Subject Headings

  • Oncology & Carcinogenesis
  • 3211 Oncology and carcinogenesis
  • 1112 Oncology and Carcinogenesis
  • 1103 Clinical Sciences